Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07046052

PENG Block: Continuous Infusion vs. Programmed Intermittent Bolus in Neck of Femur Fracture

Led by University College Cork · Updated on 2025-07-01

150

Participants Needed

1

Research Sites

92 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Pericapsular Nerve Group Block (PENG) is an effective regional anaesthesia modality in providing analgesia following neck of femur fracture. Continuous PENG techniques, using indwelling catheters and infusions of local anaesthetic, facilitate the continuation of analgesia for a number of days following hip fracture surgery. It is unclear from the published literature whether an optimal strategy of local anaesthetic delivery has been characterized. Similar doses of local anaesthetic agents can be administered by either continuous infusion or timed intermittent bolus. It is unclear whether one dosing strategy is superior to the other in the context of hip fracture analgesia. The study aims to evaluate the clinical efficacy of both dosing strategies in patients undergoing hip fracture surgery.

CONDITIONS

Official Title

PENG Block: Continuous Infusion vs. Programmed Intermittent Bolus in Neck of Femur Fracture

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • English-speaking
  • Over the age of 18 years
  • Undergoing hemiarthroplasty for fractured neck of femur
  • Able to provide written consent
Not Eligible

You will not qualify if you...

  • Weighing less than 50 kilograms
  • Unable to provide consent due to incapacity
  • Pregnant women
  • Vulnerable adults under state guardianship
  • Pre-existing chronic pain disorders or history of long-term opioid use
  • Contraindications to peripheral nerve block such as local site infection, allergy to local anaesthetic, or coagulopathy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cork University Hospital

Cork, Cork, Ireland, P85 FR62

Actively Recruiting

Loading map...

Research Team

B

Brian D O'Donnell, MBBChBAO MSc FCARCSI MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here